Evidence archive · record 79827

Tirzepatide certificate,
identity under review.

A real, dated lab record with its reported measurements visible. Pro opens the original document, verification trail and surrounding batch history.

Public evidence summaryActual record data · not an example
VendorVendor pending verification
CompoundTirzepatide
Test date2026-02-17
Testing labChromate
Source archivechromate_public
Batch IDTR30-0213

Laboratory measurements

What the lab reported

These values are transcribed from the named certificate. They are evidence from one submitted sample, not a guarantee about every vial from a vendor.

Reported laboratory resultsChecked 2026-08-15
PurityChemical purity reported on the certificate
99.81%
Measured quantityQuantity reported by the testing lab
30.37mg
Label claimQuantity stated on the submitted label
30mg
Difference from labelMeasured quantity compared with the label claim
1.23%
Endotoxin resultEndotoxin finding reported on the certificate
low

Record note: Tirzepatide batch TR30-0213 exceeds purity spec at 99.807% with acceptable endotoxin levels (<0.05 EU/mg). Minor overfill noted (+1.23%) within tolerance; sterility testing flagged growth requiring investigation.

Pro evidence trail: open the original certificate, upstream verification link, related records and vendor history.